Article Versions Notes

Zubiaur P, Matas M, Martín-Vílchez S, Soria-Chacartegui P, Villapalos-García G, Figueiredo-Tor L, Calleja S, Navares-Gómez M, de Miguel A, Novalbos J, et al. Polymorphism of Drug Transporters, Rather Than Metabolizing Enzymes, Conditions the Pharmacokinetics of Rasagiline. Pharmaceutics. 2022; 14(10):2001. https://doi.org/10.3390/pharmaceutics14102001

Zubiaur, Pablo, Miriam Matas, Samuel Martín-Vílchez, Paula Soria-Chacartegui, Gonzalo Villapalos-García, Laura Figueiredo-Tor, Sofía Calleja, Marcos Navares-Gómez, Alejandro de Miguel, Jesús Novalbos, and et al. 2022. "Polymorphism of Drug Transporters, Rather Than Metabolizing Enzymes, Conditions the Pharmacokinetics of Rasagiline" Pharmaceutics 14, no. 10: 2001. https://doi.org/10.3390/pharmaceutics14102001

Zubiaur, P., Matas, M., Martín-Vílchez, S., Soria-Chacartegui, P., Villapalos-García, G., Figueiredo-Tor, L., Calleja, S., Navares-Gómez, M., de Miguel, A., Novalbos, J., Mejía-Abril, G., Luquero-Bueno, S., Román, M., Ochoa, D., & Abad-Santos, F. (2022). Polymorphism of Drug Transporters, Rather Than Metabolizing Enzymes, Conditions the Pharmacokinetics of Rasagiline. Pharmaceutics, 14(10), 2001. https://doi.org/10.3390/pharmaceutics14102001